Three Hess Board Members Named to WomenInc. Magazine’s List of Most Influential Corporate Directors
Hess Corporation Logo header
SEARCH

Three Hess Board Members Named to WomenInc. Magazine’s List of Most Influential Corporate Directors

  • Hess---WomeinInc-Board-Directors-Recognition_V1_Newsroom
10.16.2023

WomenInc. Magazine recently announced its 2023 Most Influential Corporate Directors and included three members of Hess Corporation’s Board of Directors:

  • Lisa Glatch: Former President LNG & Net-Zero Solutions, Sempra Infrastructure
  • Edith E. Holiday: Former Assistant to the President of the United States and Secretary of the Cabinet and Former General Counsel, United States Department of the Treasury
  • Karyn F. Ovelmen: Executive Vice President & Chief Financial Officer, Newmont Corporation

As a leading business magazine reporting on women’s success and achievement, the Women Inc.’s Most Influential Corporate Directors issue is one of the most comprehensive listing of women executives, influencers and achievers contributing leadership to the boards of S&P 500/Big-Cap publicly held companies.

The full WomenInc. Most Influential Corporate Directors listing is available now online exclusively at WomenInc.

Related News
  • Hess Sustainability Efforts Featured in Ipieca-WBCSD SDG Roadmap

    The historic REDD+ Carbon Credits Purchase Agreement between Hess and the country of Guyana, announced on December 2, 2022, stands as one of the largest private-sector forest preservation pacts worldwide.
    Full story
  • Hess Launches Electric Fracturing Fleet in North Dakota

    Hess is the first operator in the Bakken to introduce electric hydraulic fracturing, replacing diesel-driven equipment to reduce CO2 emissions, and enhance operational efficiency and safety.
    Full story
  • Hess Sanctions Whiptail Development Offshore Guyana

    Hess Corporation announced it has made a final investment decision to proceed with Whiptail, the sixth development on the Stabroek Block, after receiving government and regulatory approvals.
    Full story